Volume 17, Number 6—June 2011
Dispatch
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
Table 2
Logistic regression derived odds ratios/estimates for positive HEV serology in study of prevalence and role of HEV infection among participants in the Swiss HIV Cohort Study, Switzerland, 2008*
| Variable | Odds ratio (95% CI) | p value |
|---|---|---|
| Male vs. female | 0.207 (0.041–1.016) | 0.0523 |
| CD4 100–350 vs. CD4 <100 per mm3 | 4.683 (1.268–17.295) | 0.0206 |
| CD4 >350 vs. CD4 <100 per mm3 | 2.448 (0.522–11.468) | 0.256 |
| Other ethnicity vs. Asian ethnicity | 0.295 (0.073–1.191) | 0.0864 |
| Alcohol history, no vs. yes | 1.802 (0.582–5.581) | 0.3071 |
| Risk group, other vs. MSM | 0.422 (0.100–1.774) | 0.2392 |
| Age at ALT elevation | 1.017 (0.966–1.070) | 0.5257 |
| Duration of ALT elevation | 1.001 (1.000–1.002) | 0.0207 |
*HEV, hepatitis E virus; MSM, men who have sex with men; ALT, alanine aminotransferase.
1These authors contributed equally to this article.
2These authors contributed equally to this article.


